#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15590	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2098	736.5	0	.	n	.	0	C451T	SNP	451	451	C	655	655	T	865	T,C	823,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15590	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2098	736.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1388	1388	C	894	C	841	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28744	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3457	828.0	0	.	n	.	0	T695C	SNP	695	695	T	985	985	C	869	C,T	810,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28744	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3457	828.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2261	2261	C	991	C	912	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28744	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3457	828.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2335	2335	A	946	A	895	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28744	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3457	828.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2887	2887	C	908	C,T	856,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28744	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3457	828.0	0	HET	.	.	.	A1638G,T	.	1638	1638	A	1928	1928	A	930	A,G,T	681,201,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2144	folP	855	855	100.0	folP.l15.c4.ctg.1	1465	145.4	1	SNP	p	R229S	1	.	.	685	687	AGC	984	986	AGC	211;214;215	A;G;C	197;199;199	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5728	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3543	161.3	1	SNP	p	S91F	1	.	.	271	273	TTC	740	742	TTC	179;179;176	T;T;C,T	167;170;162,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5728	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3543	161.3	1	SNP	p	D95G	1	.	.	283	285	GGC	752	754	GGC	178;180;178	G;G;C	166;169;165	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5728	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3543	161.3	1	SNP	p	G95N	0	.	.	283	285	GGC	752	754	GGC	178;180;178	G;G;C	166;169;165	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1932	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1319	146.0	1	SNP	p	G45D	0	.	.	133	135	GGC	467	469	GGC	276;274;269	G;G;C	261;262;257	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	968	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1002	95.9	0	.	n	.	0	A197.	DEL	197	197	A	561	561	A	217	A	201	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5270	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2837	184.7	1	SNP	p	D86N	0	.	.	256	258	GAC	516	518	GAC	205;204;205	G,T;A;C	194,1;190;195	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5270	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2837	184.7	1	SNP	p	R87W	0	.	.	259	261	CGT	519	521	CGT	208;213;214	C;G;T	196;199;200	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5270	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2837	184.7	1	SNP	p	R87I	0	.	.	259	261	CGT	519	521	CGT	208;213;214	C;G;T	196;199;200	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5270	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2837	184.7	1	SNP	p	S87R	1	.	.	259	261	CGT	519	521	CGT	208;213;214	C;G;T	196;199;200	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5270	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2837	184.7	1	SNP	p	S88P	0	.	.	262	264	TCC	522	524	TCC	215;218;217	T;C;C	203;207;204	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4842	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2603	185.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1475	1477	GGC	243;240;235	G;G;C	230;231;218	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	176.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1263	1265	GCC	239;237;239	G;C;C,A	232;232;234,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	176.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1266	1268	ATG	241;245;246	A;T;G	236;239;241	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	176.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1278	1280	ACC	234;233;231	A;C;C,A	220;220;217,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	176.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1278	1280	ACC	234;233;231	A;C;C,A	220;220;217,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	176.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1779	1781	ACC	252;252;255	A;C;C	232;234;237	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	176.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1833	1835	GCG	247;247;246	G;C;G	229;227;228	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	176.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1833	1835	GCG	247;247;246	G;C;G	229;227;228	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	176.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1956	1958	GGT	204;201;203	G;G;T	190;190;188	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	176.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1965	1967	AGC	184;182;183	A;G;C	173;173;172	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4312	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	176.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1983	1985	CCG	167;168;167	C,G;C,G;G	128,8;132,1;133	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6120	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3166	192.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1721	1723	CCG	214;213;209	C;C,T;G	200;198,1;195	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2268	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1837	123.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	532	532	C	158	C	151	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2990	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1632	181.9	0	.	p	.	0	G210R	NONSYN	628	630	GGA	987	989	AGA	237;237;243	A;G;A	228;226;234	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2990	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1632	181.9	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1008	1010	GGT	240;239;238	G;G;T	233;233;229	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2990	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1632	181.9	1	SNP	p	G120K	1	.	.	358	360	AAG	717	719	AAG	248;245;246	A;AG,A;G	235;237,1;230	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2990	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1632	181.9	1	SNP	p	A121N	1	.	.	361	363	AAC	720	722	AAC	251;254;256	A;A;C	238;239;240	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2990	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1632	181.9	1	SNP	p	N121D	0	.	.	361	363	AAC	720	722	AAC	251;254;256	A;A;C	238;239;240	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11196	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4813	232.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1256	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	904	137.2	1	SNP	p	V57M	1	.	.	169	171	ATG	420	422	ATG	267;265;263	A;T;G	254;250;248	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
